Duration of the protection of an E2 subunit marker vaccine against classical swine fever after a single vaccination

被引:66
|
作者
de Smit, AJ [1 ]
Bouma, A [1 ]
de Kluijver, EP [1 ]
Terpstra, C [1 ]
Moormann, RJM [1 ]
机构
[1] Inst Anim Sci & Hlth ID Lelystad, Dept Mammalian Virol, NL-8200 AB Lelystad, Netherlands
关键词
classical swine fever virus; marker vaccine; duration of protection;
D O I
10.1016/S0378-1135(00)00306-0
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The period during which pigs are protected after vaccination is important for the successful usage of a marker vaccine against classical swine fever virus (CSFV) in an eradication programme. In four animal experiments with different vaccination-challenge intervals we determined the duration of protection of an E2 subunit marker vaccine in pigs after a single vaccination. Unvaccinated pigs were included in each group to detect transmission of the challenge virus. Three groups of six pigs were vaccinated once and subsequently inoculated with the virulent CSFV strain Brescia after a vaccination-challenge interval of 3, 51/2, 6 or 13 months. All vaccinated pigs, 16 out of 18, with neutralising antibodies against CSFV at the moment of challenge, 3, 51/2, 6 or 13 months later, survived, whereas unvaccinated control pigs died from acute CSF or were killed being moribund. A proportion of the vaccinated pigs did however develop fever or cytopenia after challenge and two vaccinated pigs were viremic after challenge. Virus transmission of vaccinated and challenged pigs to unvaccinated sentinel pigs did not occur in groups of pigs which were challenged 3 or 6 months after a single vaccination. Two out of eight vaccinated pigs that were found negative for CSFV neutralising antibody at 13 months after vaccination died after subsequent challenge. The findings in this study demonstrate that pigs can be protected against a lethal challenge of CSFV for up to 13 months after a single vaccination with an E2 subunit marker vaccine. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:307 / 317
页数:11
相关论文
共 50 条
  • [31] The E2 glycoprotein of classical swine fever virus is a virulence determinant in swine
    Risatti, GR
    Borca, MV
    Kutish, GF
    Lu, Z
    Holinka, LG
    French, RA
    Tulman, ER
    Rock, DL
    JOURNAL OF VIROLOGY, 2005, 79 (06) : 3787 - 3796
  • [32] Candidate peptide vaccine induced protection against classical swine fever virus
    Dong, XN
    Wei, K
    Liu, ZQ
    Chen, YH
    VACCINE, 2002, 21 (3-4) : 167 - 173
  • [33] Interferon-gamma induction correlates with protection by DNA vaccine expressing E2 glycoprotein against classical swine fever virus infection in domestic pigs
    Tarradas, J.
    Argilaguet, J. M.
    Rosell, R.
    Nofrarias, M.
    Crisci, E.
    Cordoba, L.
    Perez-Martin, E.
    Diaz, I.
    Rodriguez, F.
    Domingo, M.
    Montoya, M.
    Ganges, L.
    VETERINARY MICROBIOLOGY, 2010, 142 (1-2) : 51 - 58
  • [34] Protection against transplacental transmission of moderately virulent classical swine fever virus using live marker vaccine "CP7_E2alf"
    Henke, Julia
    Carlson, Jolene
    Zani, Laura
    Leidenberger, Simone
    Schwaiger, Theresa
    Schlottau, Kore
    Teifke, Jens P.
    Schroeder, Charlotte
    Beer, Martin
    Biome, Sandra
    VACCINE, 2018, 36 (29) : 4181 - 4187
  • [35] AN ALTERNATIVE POTENCY TEST IN MICE FOR PORVAC®, A SUBUNIT VACCINE AGAINST CLASSICAL SWINE FEVER
    Oliva-Cárdenas, Aymé
    Vargas-Hernández, Milagros
    Martínez-Cuéllar, Yamila
    Sordo-Puga, Yusmel
    Rodríguez-Moltó, María Pilar
    Duarte, Carlos A.
    Méndez-Orta, Mary Karla
    Santana-Rodríguez, Elaine
    Sardina-González, Talia
    Fundora-Llera, Alianne
    Pérez-Pérez, Danny
    Suárez-Pedroso, Marisela F.
    Journal of Validation Technology, 2022, 28 (01)
  • [36] Evaluation of the use of a subunit classical swine fever marker vaccine under field conditions in Mexico
    Martens, M
    Rosales, C
    Morilla, A
    JOURNAL OF SWINE HEALTH AND PRODUCTION, 2003, 11 (02): : 81 - 85
  • [37] Early and Solid Protection Afforded by the Thiverval Vaccine Provides Novel Vaccination Alternatives Against Classical Swine Fever Virus
    Lamothe-Reyes, Yaneysis
    Alejandro Bohorquez, Jose
    Wang, Miaomiao
    Alberch, Monica
    Perez-Simo, Marta
    Rosell, Rosa
    Ganges, Llilianne
    VACCINES, 2021, 9 (05)
  • [38] Determination of the onset of the herd-immunity induced by the E2 sub-unit vaccine against classical swine fever virus
    Bouma, A
    De Smit, AJ
    De Jong, MCM
    De Kluijver, EP
    Moormann, RJM
    VACCINE, 2000, 18 (14) : 1374 - 1381
  • [39] Efficacy of intradermally administrated E2 subunit vaccines in reducing horizontal transmission of classical swine fever virus
    Dortmans, J. C. F. M.
    Loeffen, W. L. A.
    Weerdmeester, K.
    van der Poel, W. H. M.
    de Bruin, M. G. M.
    VACCINE, 2008, 26 (09) : 1235 - 1242
  • [40] An experimental marker vaccine and accompanying serological diagnostic test both based on envelope glycoprotein E2 of classical swine fever virus (CSFV)
    van Rijn, PA
    van Gennip, HGP
    Moormann, RJM
    VACCINE, 1999, 17 (05) : 433 - 440